• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Medical discoveries contracted out as CROs move abroad

Medical discoveries contracted out as CROs move abroad

June 7, 2012
CenterWatch Staff

Medical devices companies are outsourcing more and more of their research and development processes, reducing costs and time by conducting overseas trials, according to a new study released by GlobalData.

According to the study, contract research organizations are becoming increasingly popular with medical device companies keen to improve their financial and operational efficiency, as increasingly complex clinical trials are needed to meet the approval of regulatory bodies.

The U.S. accounts for around half of the global medical devices CRO market, valued at $1.6 billion in 2011 with growth expected to take this up to $3.4 billion by 2018. The U.S. dominates this market due to its favorable conditions for clinical research and the region’s huge medical devices market, which fuels demand for CROs.

Most major industry players are based in the U.S., but have operations based all around the world. However, cost-containment pressures in the U.S. have resulted in increasing outsourcing of clinical trials to overseas locations, leading to a boom in clinical activities in emerging regions such as India, China, Eastern Europe and Latin American countries.

A recent increase in the number of regional CROs, especially in the emerging markets of India and China, is due in part to the unique advantage of low-cost and regional regulatory expertise. Emerging economies within the Asia-Pacific region offer lucrative benefits such as easy access to patients and high patient retention rates which far outweigh the challenges involved in entering the market to conduct clinical trials. The increasing acceptance of such data from regulatory authorities in the U.S. and Europe looks to encourage the CRO market in Asia over the coming years.

However, India, China and Brazil still struggle to offer positive regulatory experiences, and intellectual property protection is a major concern for CROs and medical device companies operating here. Issues such as regulatory approval policies are therefore being tackled by the governments of these countries, who are eager to welcome business from multinational medical corporations.

The global medical devices CRO market is expected to grow at a Compound Annual Growth Rate of 12.5% over the period 2011-2018, with revenue growing from $3.2 billion in 2011 to $7.4 billion by 2018.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing